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To promote their survival, intracellular pathogens must confront microbicidal activities induced by inter-
ferons. In this issue of Cell Host & Microbe, Fentress et al. show that Toxoplasma gondii evades intracellular
killing by deploying a virulence determinant, ROP18, which acts by directly phosphorylating and disabling an
IFN-g-inducible immunity-related GTPase involved in pathogen clearance.Toxoplasma gondii is an obligate intracel-
lular parasite. Upon infection, the path-
ogen resides in parasitophorous vacuoles
of host cells. The majority of Toxoplasma
isolates belong to one of three distinct
clonal lineages, types I, II, and III. In immu-
nocompetent mice, the three types of
T. gondii display significant differences
in virulence, with type I being hyperviru-
lent and type II and III strains avirulent.
The molecular basis for this strain-
specific difference in the behavior of
T. gondii isolates is a hotly pursued area
of investigation.
Host resistance against T. gondii
requires the generation of T helper 1 lym-
phocytes that produce IFN-g, a cytokine
essential for cellular activation and para-
site killing. IFN-g induces a large group
of microbicidal molecules that includes
nitric oxide and an interesting family of
47 kDa immunity-related GTPases (IRGs).
Experiments with knockout animals have
indicated that the latter proteins possess
a broad range of antimicrobial and regu-
latory functions that play a critical role
in host defense against a variety of
intracellular bacterial and parasitic patho-
gens (Hunn et al., 2010). Irgm1 and Irgm3,
the two best-studied members of the
IRG family, have previously been shown
to be required for resistance to T. gondii
infection in vivo as well as IFN-g-depen-
dent restriction of parasite replication in
macrophages (Hunn et al., 2010). Infec-
tion with avirulent strains of Toxoplasma
in vitro is associated with the rapid
trafficking and recruitment of multiple
IRGs to the membrane of the vacuoles in
which the parasite resides, with Irgb6
and Irgb10 being the most prominent
IRG proteins recruited (Khaminets et al.,2010; Zhao et al., 2009). Interestingly,
when virulent type I Toxoplasma strains
were used for infection in the same
system, the loading to the parasitopho-
rous vacuoles of IRG proteins and in
particular Irgb6 was found to be signifi-
cantly reduced, suggesting a role for this
process in parasite virulence.
In recent years, there have been major
breakthroughs utilizing elegant genetic
approaches to decipher the molecular
basis of virulence in T. gondii (Saeij et al.,
2006, 2007; Taylor et al., 2006). These
studies involvinggenetic crossesbetween
parasite strains with different virulence
phenotypes have revealed a major role
for the Toxoplasma rhoptry proteins
(ROPs), ROP18 and ROP16, in virulence
determination. Rhoptries are secretory
organelles that discharge their contents
during parasite invasion of host cells. The
ROPs released during this process can
enter the cytosol and, in the case of
ROP16, transit to the nucleus. In previous
studies, ROP16 was found to regulate
expression of host genes involved in
macrophage activation through its phos-
phorylation of STAT3 and STAT6 (Saeij
et al., 2007; Yamamoto et al., 2009). An
article in this issue of Cell Host & Microbe
now reveals a second parasite immune
evasion strategy employed by virulent
T. gondii strains involving the phosphory-
lation by ROP18 of Irgb6, an IRG protein
with a previously undefined role in host
defense (Fentress et al., 2010).
ROP18 is a highly polymorphic serine-
threonine kinase. After release into the
cytosol of host cells, ROP18 is targeted
to the parasitophorous vacuole mem-
brane (Ha˚kansson et al., 2001). Trans-
genic expression of ROP18 from a type ICell Host & Microbe 8, Dstrain in a type III strain that is normally
avirulent led to a significant increase in
virulence during mouse infection (Taylor
et al., 2006). Although the function of
ROP18 is not fully understood, it has
been shown to phosphorylate parasitic
substrates, and overexpression of the
kinase results in an increase in the rate
of intravacuolar parasite replication
in vitro (El Hajj et al., 2007). In the current
study reported in Cell Host and Microbe,
Fentress et al. (2010) demonstrate that
ROP18 from a type I strain phosphory-
lates Irgb6, thereby inhibiting the recruit-
ment of the GTPase to parasite vacuoles,
resulting in impaired parasite clearance.
Although inactivation of the GTPase by
phosphorylation of Irgb6 was not formally
demonstrated, the authors nevertheless
speculate that this processmay represent
a novelmechanismbywhich virulent type I
parasites resist killing by IFN-g-inducible
GTPases.
The findings reported by Fentress et al.
are consistent with previous observations
that infection with virulent type I T. gondii
strains is associated with impaired
recruitment of IRGs to parasite vacuoles
and that IRG proteins protect cells against
avirulent but not virulent Toxoplasma
strains (Khaminets et al., 2010; Zhao
et al., 2009). However, in contrast to the
current study, a direct role for ROP18 in
inhibiting the recruitment of IRGs to Toxo-
plasma vacuoles was not apparent in the
previous publications examining this
question (Khaminets et al., 2010; Zhao
et al., 2009). The exact reasons for the
discrepancy are unclear.
Regardless, the current findings raise
several fascinating questions. What is
the relative contribution of individualecember 16, 2010 ª2010 Elsevier Inc. 463
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PreviewsIRGs, as well as nitric oxide, in the overall
mechanism of parasite killing in IFN-g-
activated macrophages? Why is the
defect in parasite killing resulting from
the silencing of Irgb6 not compensated
for by IFN-g-induced Irgm1 or Irgm3? In
addition, because Irgms and other IRGs
share the conserved region of Irgb6 tar-
geted by ROP18, why are these GTPases
not inactivated by ROP18 by the same
mechanism? In this regard, the current
and a recent study have reported that
ROP18 is indeed also able to phosphory-
late Irga6 and Irgb10 (Steinfeldt et al.,
2010). A further question concerns
whether RPO18 is sufficient and acts as
the sole determinant of virulence among
the diverse range of T. gondii strains and
whether other strain-specific kinases ex-
pressed in non-type I lineages play
a related role.
Interestingly, the remarkable difference
in the virulence among the three major
types of Toxoplasma in mice does not
appear to be recapitulated in humans.
Moreover, the host targets of ROP18 in
mice, Irga6, Irgb6, and Irgb10, are absent464 Cell Host & Microbe 8, December 16, 201in human cells (Hunn et al., 2010), sug-
gesting that this parasite virulence factor
may have coevolved with the IRG family.
Thus, it appears that ROP18 is utilized
by Toxoplasma to specifically counteract
the effector functions of the IRG family,
one of the most powerful host mecha-
nisms for defense against intracellular
pathogens documented in nonprimate
mammalian species.ACKNOWLEDGMENTS
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Oncogenic viruses infect many cells but rarely lead to tumorigenesis. In this issue of Cell Host & Microbe,
Nikitin et al. describe how a protective DNA damage response acts to suppress transformation in themajority
of cells latently infected with Epstein-Barr virus (EBV).Although genomic instability is a hallmark
of almost all human cancers, in most
cases it is still unclear how it arises and
contributes to tumorigenesis. In heredi-
tary cancers, germline mutations provide
an explanation for the initiation of genome
instability, but in sporadic cancers, the
molecular basis for the sourceof instability
is often unknown (Negrini et al., 2010).
Recent studies in cancer biology have
proposed that activation of the DNAdamage response (DDR) in early precan-
cerous lesions presents a barrier to tumor
progression (Halazonetis et al., 2008).
Activated oncogenes induce hyperprolif-
eration and replication stress, resulting in
DNA double-strand breaks (DSBs) that
induce the DDR (Figure 1). This response
activates the p53 tumor suppressor and
triggers cell-cycle arrest, senescence, or
apoptosis. The DDR in precancerous
lesions therebyacts asan inducible barrieragainst genomic instability, restricting
tumorigenesis (Bartkova et al., 2005; Gor-
goulis et al., 2005). This imposes a selec-
tive pressure for acquisition of mutations
that compromise the checkpoint, and
during cancer progression these defects
result in suppression of signaling, facili-
tating escape from apoptosis and senes-
cence (Halazonetis et al., 2008).
The DDR represents a cellular surveil-
lance network of signaling pathways that
